Kusha Mohammadi
7PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 23, 2025
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.Gregory P Geba, Kusha A Mohammadi, Amy Damask
|May 13, 2025
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial.Dinko Gonzalez Trotter, Stephen Donahue, Chris Wynne
|Nov 06, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.Christopher D Petro, Andrea T Hooper, Avery Peace
|Sep 28, 2023
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo
|Mar 22, 2022
Mediating Effects of Neighborhood-Level Socioeconomic Deprivation on the Association Between Race/Ethnicity and Advanced Hepatocellular Carcinoma.Abiodun O Oluyomi, Kusha A Mohammadi, Hashem B El-Serag
Pageof 2
Frequent Collaborators
3 joint publications
Gary A Herman
2 joint publications
Mark G Lewis
2 joint publications
Eduardo Forleo-Neto
2 joint publications
Andrew J Murphy
2 joint publications
Robert Pordy
2 joint publications
Hanne Andersen
2 joint publications
Christos A Kyratsous
2 joint publications
Bret Musser
2 joint publications
Alina Baum
1 joint publications
Hashem B El-Serag